The applicant’s expertise in computational neuroscience, pharmacological modeling, and AI‑driven drug‑resistance prediction aligns well with CHAI’s focus on AI safety and control. While the fellowship is post‑doctoral, the candidate’s strong interdisciplinary background and existing collaborations with leading AI and neuroscience researchers make them a promising fit, though the lack of a PhD may be a minor hurdle.